Eagle's Eye View: Day 3 Highlights | TCT 2022
Listen now
Description
In this special episode of Eagle’s Eye View, Drs. Deepak Bhatt, Bina Ahmed and Roxana Mehran discuss highlights from Day 3 of the TCT 2022 late-breaking science, including PCSK9 Inhibition, FAVOR III China, and SCAAR. The ACC is providing coverage of the hottest TCT 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC’s Meeting Coverage page and follow the ACC on social media using the hashtag #TCT2022 to join the conversation.
More Episodes
In this week’s View, Dr. Eagle looks at a systematic review and meta-analysis of antibiotic prophylaxis and infective endocarditis incidence following invasive dental procedures. He then examines the issue of serious bleeding in patients with atrial fibrillation using diltiazem with apixaban or...
Published 04/17/24
In this special edition of Eagle’s Eye View, Dr. Eagle introduces you to ACC24 featuring valuable insights into practice-changing updates in care. The topics include late-breaking clinical trials and science focusing on new drugs and device therapies.
Tune into ACC.org’s coverage of ACC.24...
Published 04/10/24
Published 04/10/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
